← Human Trials & Peer-Reviewed Studies

Vitamin D status and clinical implications in the adult population of Malaysia: a position paper by the Malaysian Vitamin D Special Interest Group.

Plain-language guide to PMID 37430004 (2023): review of Vitamin D, K2, Magnesium and Zinc.

Key Facts

PMID
37430004
Journal
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Year
2023
Study type
Review
Authors
Lee JK et al. (14 authors)
DOI
10.1007/s00198-023-06841-4

What This Paper Covers, in Plain Language

What It Covers

Researchers studied Vitamin D, K2, Magnesium and Zinc in this review publication.

Vitamin D deficiency and insufficiency is common among populations globally, and in Asia and Malaysia.

The purpose of this Position Paper is to propose recommendations for both clinicians and non-clinicians to promote vitamin D sufficiency in Malaysian adults.

Who the Included Studies Covered

By PubMed's age tags, the people studied were adults.

Literature reviews were undertaken to inform summaries of the following: vitamin D status globally and in Asian and Malaysian populations, vitamin D status among individuals with common medical conditions, and current recommendations to achieve vitamin D sufficiency through sun exposure, food intake and supplementation.

Recommendations were based on the findings of the literature reviews, recent European guidance on vitamin D supplementation, the 2018 road map for action on vitamin D in low- and middle-income countries, and research recommendations proposed by the Malaysian Ministry of Health in 2017.

What Was Measured

The subject headings attached to it are Vitamin D Deficiency, Malaysia, Vitamin D, Dietary Supplements, Sunlight, Food, Fortified and Nutritional Status.

The authors tagged it with the keywords Sun exposure and Supplementation.

What This Means in Plain Language

This is a review of Vitamin D, K2, Magnesium and Zinc.

Results are reported in around 3 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2023 (Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.